Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Multiple Sclerosis

  Free Subscription


1 BMC Neurol
1 J Neuroimmunol
2 J Neurol
3 Mult Scler
4 Neurology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Neurol

  1. SELLITTO G, Ruotolo I, Ianniello A, Felicetti F, et al
    Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS.
    BMC Neurol. 2024;24:138.
    PubMed         Abstract available

    J Neuroimmunol

  2. LI V, Binder MD, Purcell AW, Kilpatrick TJ, et al
    Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis.
    J Neuroimmunol. 2024;390:578347.
    PubMed         Abstract available

    J Neurol

  3. ROSENSTEIN I, Nordin A, Sabir H, Malmestrom C, et al
    Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis.
    J Neurol. 2024 Apr 26. doi: 10.1007/s00415-024-12389.
    PubMed         Abstract available

  4. NAUTA IM, van Dam M, Bertens D, Kessels RPC, et al
    Improved quality of life and psychological symptoms following mindfulness and cognitive rehabilitation in multiple sclerosis and their mediating role for cognition: a randomized controlled trial.
    J Neurol. 2024 Apr 23. doi: 10.1007/s00415-024-12327.
    PubMed         Abstract available

    Mult Scler

  5. MANUEL AM, Gottlieb A, Freeman L, Zhao Z, et al
    Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data.
    Mult Scler. 2024 Apr 25:13524585241240398. doi: 10.1177/13524585241240398.
    PubMed         Abstract available

  6. BIANCHI A, Cortese R, Prados F, Tur C, et al
    Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
    Mult Scler. 2024 Apr 22:13524585241240420. doi: 10.1177/13524585241240420.
    PubMed         Abstract available

  7. NOVAK F, Bajwa HM, Ostergaard K, Berg JM, et al
    Extended interval dosing with ocrelizumab in multiple sclerosis.
    Mult Scler. 2024 Apr 22:13524585241245296. doi: 10.1177/13524585241245296.
    PubMed         Abstract available


    Right Brain: The Unraveling.
    Neurology. 2024;102:e209492.
    PubMed         Abstract available

  9. VYAS MV, Kapral MK, Alonzo R, Fang J, et al
    Proportion of Life Spent in Canada and the Incidence of Multiple Sclerosis in Permanent Immigrants.
    Neurology. 2024;102:e209350.
    PubMed         Abstract available

  10. SILBERMANN E, Spain RI
    Serum Neurofilament Light Chain for Multiple Sclerosis Relapses: Too Little Too Late?
    Neurology. 2024;102:e209456.

  11. FOX RJ, Cree BAC, de Seze J, Gold R, et al
    Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
    Neurology. 2024;102:e209357.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.